000			02179 a2200577 4500
005			20250516072951.0
264		0	_c20120829
008			201208s 0 0 eng d
022			_a1755-148X
024	7		_a10.1111/j.1755-148X.2012.00970.x _2doi
040			_aNLM _beng _cNLM
100	1		_aMadhunapantula, SubbaRao V
245	0	0	_aTargeting sphingosine kinase-1 to inhibit melanoma. _h[electronic resource]
260			_bPigment cell & melanoma research _cMar 2012
300			_a259-74 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Adhesion _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCyclin D1 _xmetabolism
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aG1 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aHumans
650	0	4	_aLysophospholipids _xmetabolism
650	0	4	_aMelanocytes _xdrug effects
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMice
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aPhosphotransferases (Alcohol Group Acceptor) _xantagonists & inhibitors
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRNA, Small Interfering _xmetabolism
650	0	4	_aResting Phase, Cell Cycle _xdrug effects
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aSphingosine _xanalogs & derivatives
650	0	4	_aStaurosporine _xpharmacology
650	0	4	_aThiazoles _xpharmacology
650	0	4	_aUp-Regulation _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aHengst, Jeremy
700	1		_aGowda, Raghavendra
700	1		_aFox, Todd E
700	1		_aYun, Jong K
700	1		_aRobertson, Gavin P
773	0		_tPigment cell & melanoma research _gvol. 25 _gno. 2 _gp. 259-74
856	4	0	_uhttps://doi.org/10.1111/j.1755-148X.2012.00970.x _zAvailable from publisher's website
999			_c21453003 _d21453003